Equities Research Analysts' downgrades for Tuesday, March 7th:

Anika Therapeutics (NASDAQ:ANIK) was downgraded by analysts at Barrington Research from an outperform rating to a market perform rating.

Aptinyx (NASDAQ:APTX) was downgraded by analysts at HC Wainwright from a buy rating to a neutral rating.

CareDx (NASDAQ:CDNA) was downgraded by analysts at Stephens from an overweight rating to an equal weight rating. Stephens currently has $9.00 price target on the stock, down from their previous price target of $19.00.

Clarkson (LON:CKN) was downgraded by analysts at JPMorgan Chase & Co. to a neutral rating. They currently have GBX 3,740 ($44.97) target price on the stock, down from their previous target price of GBX 4,050 ($48.70).

Clarkson (OTCMKTS:CKNHF) was downgraded by analysts at JPMorgan Chase & Co. from an overweight rating to a neutral rating.

Collegium Pharmaceutical (NASDAQ:COLL) was downgraded by analysts at StockNews.com from a buy rating to a hold rating.

ENI (NYSE:E) was downgraded by analysts at StockNews.com from a buy rating to a hold rating.

Embark Technology (NASDAQ:EMBK) was downgraded by analysts at Robert W. Baird from an outperform rating to a neutral rating.

Eaton (NYSE:ETN) was downgraded by analysts at StockNews.com from a strong-buy rating to a buy rating.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) was downgraded by analysts at HSBC Holdings plc from a hold rating to a reduce rating.

Globe Life (NYSE:GL) was downgraded by analysts at StockNews.com from a buy rating to a hold rating.

Gossamer Bio (NASDAQ:GOSS) was downgraded by analysts at Raymond James from an outperform rating to a market perform rating.

Hana Microelectronics Public (OTCMKTS:HNMUF) was downgraded by analysts at Credit Suisse Group AG from an outperform rating to a neutral rating.

Joby Aviation (NYSE:JOBY) was downgraded by analysts at Deutsche Bank Aktiengesellschaft from a hold rating to a sell rating. The firm currently has $4.00 price target on the stock, down from their previous price target of $6.00.

Lightspeed Commerce (NYSE:LSPD) was downgraded by analysts at Moffett Nathanson from an outperform rating to a market perform rating. They currently have $17.00 target price on the stock, down from their previous target price of $23.00.

Marin Software (NYSE:MRIN) was downgraded by analysts at StockNews.com from a hold rating to a sell rating.

Office Properties Income Trust (NASDAQ:OPI) was downgraded by analysts at Royal Bank of Canada from a sector perform rating to an underperform rating. The firm currently has $14.00 price target on the stock, down from their previous price target of $16.00.

Ovintiv (NYSE:OVV) was downgraded by analysts at BMO Capital Markets from an outperform rating to a market perform rating. They currently have $51.00 target price on the stock, down from their previous target price of $56.00.

Paramount Group (NYSE:PGRE) was downgraded by analysts at StockNews.com from a hold rating to a sell rating.

Puma (OTCMKTS:PUMSY) was downgraded by analysts at UBS Group AG from a buy rating to a neutral rating.

Rathbones Group (OTCMKTS:RTBBF) was downgraded by analysts at Berenberg Bank from a buy rating to a hold rating.

Rightmove (OTCMKTS:RTMVY) was downgraded by analysts at Peel Hunt to a hold rating.

Rolls-Royce Holdings plc (OTCMKTS:RYCEY) was downgraded by analysts at Barclays PLC from an overweight rating to an equal weight rating.

Secure Energy Services (OTCMKTS:SECYF) was downgraded by analysts at Royal Bank of Canada from an outperform rating to a sector perform rating.

SMC (OTCMKTS:SMCAY) was downgraded by analysts at Credit Suisse Group AG from an outperform rating to a neutral rating.

Skandinaviska Enskilda Banken AB (publ) (OTCMKTS:SVKEF) was downgraded by analysts at Deutsche Bank Aktiengesellschaft from a hold rating to a sell rating.

TCR2 Therapeutics (NASDAQ:TCRR) was downgraded by analysts at HC Wainwright from a buy rating to a neutral rating.

Trimble (NASDAQ:TRMB) was downgraded by analysts at Northcoast Research from a neutral rating to a sell rating. They currently have $40.00 price target on the stock.

Receive News & Ratings for Anika Therapeutics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anika Therapeutics Inc and related companies with MarketBeat.com's FREE daily email newsletter.